[1]
“OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, Feb. 2026, doi: 10.4084/MJHID.2026.022.